openPR Logo
Press release

Monoclonal Antibodies Market 2020 - Pfizer Inc., Novartis AG, Bayer AG, Sanofi S.A., F. Hoffmann-La Roche AG, Eli Lilly and Co., Merck & Co., Inc

02-04-2021 09:21 AM CET | Health & Medicine

Press release from: busines news

Monoclonal Antibodies Market

Monoclonal Antibodies Market

CMI analyses the Monoclonal Antibodies trends, by country, for a five year review period (2020-2027) forecast period. Our regular clients asked us to produce detailed market segmentation, and this is what you will find here: a report without any unnecessary padding, giving a unique analysis of the sector.

Major Companies Covered in this report:-
1 Pfizer Inc.*
2 Novartis AG.
3 Bayer AG.
4 Sanofi S.A.
5 Hoffmann-La Roche AG.
6 Eli Lilly and Co.
7 Merck & Co., Inc.
8 GlaxoSmithKline Plc.

Request For Sample Copy of the Report @
https://www.coherentmarketinsights.com/insight/request-sample/2403

Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases.

Rising incidence of cancer and other chronic diseases is a major factor that is expected to boost the monoclonal antibodies market growth over the forecast period. According to GLOBOCAN, in 2018, an estimated 43.6% new cases of breast cancer were registered in Asia Pacific. Also, according to the American Cancer Society, 2017, cancer was the second most common cause of death in the U.S., which accounted for around 1 out of every 4 deaths.

Get up to 30% Discount on this Premium Report @:
https://www.coherentmarketinsights.com/insight/request-discount/2403

Market players are focused on combining monoclonal antibodies with other therapies such as chemotherapy drugs, which is expected to assist the market growth over the forecast period. For instance, combination of nivolumab and ipilimumab for the treatment of intermediate- or poor-risk patients with previously untreated advanced renal cell carcinoma was approved in the U.S. in 2018 and in January 2019 in Europe.

Moreover, efforts of manufacturers to increase number of indications (oncology) for monoclonal antibodies is further expected to boost the market growth over the forecast period. For instance, in June 2018, the U.S. Food & Drug Administration (FDA) expanded the indication of pembrolizumab (Keytruda) to include recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.

Major players operating in the global monoclonal antibodies market include Pfizer Inc., Novartis AG, Bayer AG, Sanofi S.A., F. Hoffmann-La Roche AG, Eli Lilly and Co., Merck & Co., Inc., GlaxoSmithKline Plc., AbbVie Inc., Bristol-Myers Squibb, and Regeneron Pharmaceuticals Inc.

Apply Promo Code “STAYHOME” and Get Up to 30% Discount

If you purchase the report this year:

Buy This Complete A Business Report:
https://www.coherentmarketinsights.com/insight/buy-now/2403

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Monoclonal Antibodies Market 2020 - Pfizer Inc., Novartis AG, Bayer AG, Sanofi S.A., F. Hoffmann-La Roche AG, Eli Lilly and Co., Merck & Co., Inc here

News-ID: 2236139 • Views:

More Releases from busines news

Latest Research Of The Hip Replacement Market 2020 New Opportunities | Depuy Synthes (Johnson & Johnson), Microport Scientific Corporation, Zimmer Biomet, Exactech
Latest Research Of The Hip Replacement Market 2020 New Opportunities | Depuy Syn …
Coherent Market Insights has recently added a new research report to its mega database of research studies. The research report, titled “Global Hip Replacement Market Report 2020 is latest research report, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Hip Replacement Market. Additionally, the Hip
Cell and Gene Therapy Market 2020 - Amgen, Biogen, BioMarin Pharmaceuticals, Bristol-Myers Squibb Company, GlaxoSmithKline, Novartis, Pfizer
Cell and Gene Therapy Market 2020 - Amgen, Biogen, BioMarin Pharmaceuticals, Bri …
CMI analyses the Cell and Gene Therapy trends, by country, for a five year review period (2020-2027) forecast period. Our regular clients asked us to produce detailed market segmentation, and this is what you will find here: a report without any unnecessary padding, giving a unique analysis of the sector. Major Companies Covered in this report:- 1 Amgen * 2 Biogen 3 BioMarin Pharmaceuticals 4 Bristol-Myers Squibb Company 5 GlaxoSmithKline 6 Novartis 7 Pfizer Request For Sample Copy of
Ovarian Cancer Drugs Market 2020 - Bristol Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc
Ovarian Cancer Drugs Market 2020 - Bristol Myers Squibb Company, Eli Lilly and C …
CMI analyses the Ovarian Cancer Drugs trends, by country, for a five year review period (2020-2027) forecast period. Our regular clients asked us to produce detailed market segmentation, and this is what you will find here: a report without any unnecessary padding, giving a unique analysis of the sector. Major Companies Covered in this report: Bristol Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc., Novogen, Inc., Genentech Inc.,
Lung Cancer Therapeutics Market 2020 - Pfizer, Celgene, F. Hofmann-La Roche, AstraZeneca and Eli Lilly
Lung Cancer Therapeutics Market 2020 - Pfizer, Celgene, F. Hofmann-La Roche, Ast …
CMI analyses the Lung Cancer Therapeutics trends, by country, for a five year review period (2020-2027) forecast period. Our regular clients asked us to produce detailed market segmentation, and this is what you will find here: a report without any unnecessary padding, giving a unique analysis of the sector. Major Companies Covered in this report: Pfizer, Celgene, F. Hofmann-La Roche, AstraZeneca and Eli Lilly. Request a Sample Copy of the Report @ https://www.coherentmarketinsights.com/insight/request-sample/702 Lung

All 5 Releases


More Releases for Monoclonal

Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibo …
"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The arthritis monoclonal antibodies
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031." The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02
Monoclonal Antibody Therapy Market - Empowering the immune system: Monoclonal an …
Newark, New Castle, USA: The "Monoclonal Antibody Therapy Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Monoclonal Antibody Therapy Market: https://www.growthplusreports.com/report/monoclonal-antibody-therapy-market/7736 This latest report researches the industry structure,
Impact COVID-19 on Monoclonal Antibodies Market 2021 Generated Opportunities for …
Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. For instance, in 2017,